![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Found 6 studies with search of: | "Lurtotecan" |
Hide studies that are not seeking new volunteers.
|
|
1 | Completed | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | ||||
Conditions: | SCLC; Carcinoma, Small Cell | |||||
Intervention: | Drug: OSI-211 (Liposomal Lurtotecan) | |||||
2 | Completed | Study of OSI-211 Vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer | ||||
Condition: | Ovarian Neoplasms | |||||
Intervention: | Drug: OSI-211 (Liposomal Lurtotecan) | |||||
3 | Active, not recruiting | Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer | ||||
Condition: | Head and Neck Cancer | |||||
Intervention: | Drug: lurtotecan liposome | |||||
4 | Active, not recruiting | Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors | ||||
Condition: | Unspecified Adult Solid Tumor, Protocol Specific | |||||
Intervention: | Drug: lurtotecan liposome | |||||
5 | Active, not recruiting | Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer | ||||
Conditions: | Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer | |||||
Intervention: | Drug: lurtotecan liposome | |||||
6 | Active, not recruiting | Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | ||||
Conditions: | Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Unspecified Adult Solid Tumor, Protocol Specific | |||||
Interventions: | Drug: cisplatin; Drug: lurtotecan liposome | |||||
![]() |